May 22, 2020 This committee review grant applications for Pre-doctoral, Post-doctoral and Research Starter Grants dealing with innovative approaches that…
Read More
The second in a series of three studies measured the pharmacokinetic and heart rate effects of intranasal epinephrine in dogs….
Read More
April 13, 2020 Mesa Science Associates Inc. (MSA) and Bryn Pharma LLC published the findings from the first of three…
Read More
March 16, 2020 MSA has submitted three manuscripts in high impact journals that report the results of pre-clinical experiments evaluating…
Read More
February 17, 2020 Over the past two years, MSA has worked closely with Bryn Pharma to develop a new system…
Read More
January 15, 2020 MSA recently made significant upgrades to our office space located within the Frederick Innovation Technology Center. Each…
Read More
November 14, 2019 On November 10, 2019, Mr. Michael Mesa, President and CEO of Mesa Science Associates (MSA), announced the…
Read More
November 13, 2019 Preclinical Study of Intranasal Epinephrine Administration in Nasal Congestion Model Demonstrated Faster Absorption of Epinephrine in Canines…
Read More
November 9, 2017 Dr. Ken Dretchen, Chief Scientific Officer served as a member of the Basic Pharmacology Advisory Committee for…
Read More
June 14, 2017 During the week beginning Sunday 6/11/17 Michael Mesa , President of Mesa Science Associates , will represent…
Read More